Form 4 for MAIA MAIA Biotechnology, Inc.
Accepted 2025-03-05 00:00:00 ET · period of report 2025-03-03 · accession 0001127602-25-008330 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-05 | 2025-03-03 | MAIA | Guerrero Ramiro | Dir | P - Purchase | $1.50 | +33.3K | 568.2K | +6% | +$50.0K |
| D | 2025-03-05 | 2025-03-03 | MAIA | Guerrero Ramiro | Dir | P - Purchase | $1.85 | +33.3K | 33.3K | New | +$61.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-03 | P | A | 33,333 | $1.50 | 568,218 | D | — | — | (F1) The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on March 3, 2025. |
| 2 | Derivative | Warrants | 2025-03-03 | P | A | 33,333 | $1.85 | 33,333 | D | $1.85 · 2026-03-03 to 2031-03-03 | 33,333 Common Stock | (F2) These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on March 3, 2025. The options are exercisable beginning on the one-year anniversary of the issuance date and expire 6-years after the initial issuance date. |